Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions

2017 ◽  
Vol 14 (8) ◽  
Author(s):  
Mohammad Kazem Khoeeniha ◽  
Mehdi Esfandyari-Manesh ◽  
Hossein Behrouz ◽  
Mohsen Amini ◽  
Behrang Shiri Varnamkhasti ◽  
...  
Tumor Biology ◽  
2017 ◽  
Vol 39 (3) ◽  
pp. 101042831769226 ◽  
Author(s):  
Peng Yang ◽  
Bing Li ◽  
Qi-Feng Yin ◽  
Yu-Juan Wang

The combination of nanotechnology and medicine will be the next generation of vehicles for targeted drug delivery. Carboxymethyl chitosan loaded with the anticancer drug C-phycocyanin and the CD59-specific ligand peptide for cancer cell targeting were used to create C-phycocyanin/carboxymethyl chitosan–CD59-specific ligand peptide nanoparticles using the ionic-gelation method. Optimal synthesis conditions, selected by response surface methodology, comprised the ratio carboxymethyl chitosan:C-phycocyanin = 3:1, and carboxymethyl chitosan and CaCl2 concentrations of 2.0 and 1.0 mg/mL, respectively. The resulting nanoparticles were spherical, with diameters of approximately 200 nm; the entrapment efficient was about 65%; and the drug loading was about 20%. The release of C-phycocyanin from C-phycocyanin/carboxymethyl chitosan nanoparticles was pH sensitive and had a sustainable effect in vitro. Guided by the CD59-specific ligand peptide, the nanoparticles efficiently targeted the surface of HeLa cells and had an obvious inhibitory effect on HeLa cell proliferation as determined by methyl thiazolyl tetrazolium assays. The nanoparticles were hemocompatible and induced apoptosis by upregulation of cleaved caspase-3 and cleaved polyADP-ribose polymerase proteins, and downregulation of Bcl-2 proteins. Our study provides a novel approach to the research and development of marine drugs, and support for targeted therapy using anticancer drugs.


2014 ◽  
Vol 39 (4) ◽  
pp. 423-425 ◽  
Author(s):  
Nobuya Hiroshiba ◽  
Yuri Tabata ◽  
Sho Yamauchi ◽  
Yo Ichikawa

Synlett ◽  
1989 ◽  
Vol 1989 (01) ◽  
pp. 30-32
Author(s):  
Thomas V. Lee ◽  
Alistair J. Leigh ◽  
Christopher B. Chapleo

2020 ◽  
pp. 1-18
Author(s):  
Yu.V. Bilokopytov ◽  
◽  
S.L. Melnykova ◽  
N.Yu. Khimach ◽  
◽  
...  

CO2 is a harmful greenhouse gas, a product of chemical emissions, the combustion of fossil fuels and car exhausts, and it is a widely available source of carbon. The review considers various ways of hydrogenation of carbon dioxide into components of motor fuels - methanol, dimethyl ether, ethanol, hydrocarbons - in the presence of heterogeneous catalysts. At each route of conversion of CO2 (into oxygenates or hydrocarbons) the first stage is the formation of CO by the reverse water gas shift (rWGS) reaction, which must be taken into account when catalysts of process are choosing. The influence of chemical nature, specific surface area, particle size and interaction between catalyst components, as well as the method of its production on the CO2 conversion processes is analyzed. It is noted that the main active components of CO2 conversion into methanol are copper atoms and ions which interact with the oxide components of the catalyst. There is a positive effect of other metals oxides additives with strong basic centers on the surface on the activity of the traditional copper-zinc-aluminum oxide catalyst for the synthesis of methanol from the synthesis gas. The most active catalysts for the synthesis of DME from CO2 and H2 are bifunctional. These catalysts contain both a methanol synthesis catalyst and a dehydrating component, such as mesoporous zeolites with acid centers of weak and medium strength, evenly distributed on the surface. The synthesis of gasoline hydrocarbons (≥ C5) is carried out through the formation of CO or CH3OH and DME as intermediates on multifunctional catalysts, which also contain zeolites. Hydrogenation of CO2 into ethanol can be considered as an alternative to the synthesis of ethanol through the hydration of ethylene. High activation energy of carbon dioxide, harsh synthesis conditions as well as high selectivity for hydrocarbons, in particular methane remains the main problems. Further increase of selectivity and efficiency of carbon dioxide hydrogenation processes involves the use of nanocatalysts taking into account the mechanism of CO2 conversion reactions, development of methods for removing excess water as a by-product from the reaction zone and increasing catalyst stability over time.


2015 ◽  
Vol 37 (4) ◽  
pp. 402-407
Author(s):  
S.V. Zhil’tsova ◽  
◽  
V.M. Mikhal’chuk ◽  
N.G. Leonova ◽  
R.I. Lyga ◽  
...  

2019 ◽  
Vol 9 (02) ◽  
Author(s):  
Sharma Pankaj ◽  
Tailang Mukul

The aim of present work was to prepare colon specific delivery system of Ornidazole using different ratio of shellac, zein and guar gum. From study of various literature it revealed that shellac, zein and guar gum released drug from dosage form at the pH of 6.9, 11.5, 7-9 respectively. The main problem associated with colon targeted drug delivery system is degradation of drug in the acidic environment of stomach to circumvent the present problem different combinations of shellac, zein and guar gum were employed in the formulation of colon targeted tablet. Several preformulation parameters were determined such as melting point, FTIR spectroscopy, preparation of calibration curve, determination of λmax and partition coefficient. After the preformulation studies, next steps were preparation of core tablets, evaluation of core of tablets and coating of tablets. The data obtained from preformulation study seven formulations were developed and evaluated for various parameters. Based on evaluated parameter such as weight variation, friability, dissolution study, invitro drug release etc. the F7 formulation show better results colon targeted tablets. Drug content in F7 formulation was 95% and drug release after 6 hrs was 96%. Formulation containing combination of shellac, zein and guar gum released least amount of drug in the acidic environment of stomach and released most of the drug in colon. It is evide


2020 ◽  
Author(s):  
Xizheng Sun ◽  
Reika Tokunaga ◽  
Yoko Nagai ◽  
Ryo Miyahara ◽  
Akihiro Kishimura ◽  
...  

<p><a></a><a></a><a>We have validated that ligand peptides designed from antigen peptides could be used for targeting specific major histocompatibility complex class I (MHC-I)</a> molecules on cell surface. To design the ligand peptides, we used reported antigen peptides for each MHC-I molecule with high binding affinity. From the crystal structure of the peptide/MHC-I complexes, we determined a modifiable residue in the antigen peptides and replaced this residue with a lysine with an ε-amine group modified with functional molecules. The designed ligand peptides successfully bound to cells expressing the corresponding MHC-I molecules via exchange of peptides bound to the MHC-I. We demonstrated that the peptide ligands could be used to transport a protein or a liposome to cells expressing the corresponding MHC-I. The present strategy may be useful for targeted delivery to cells overexpressing MHC-I, which have been observed autoimmune diseases.</p>


Sign in / Sign up

Export Citation Format

Share Document